Loading...
By the Editors
The U.S. Preventive Services Task Force has finalized its recommendations against hormone therapy for preventing chronic conditions in postmenopausal women. The grade D recommendations, published in JAMA, are in line with the group's prior guidance.
The recommendations do not apply to hormone therapy for the treatment of menopausal symptoms, such as hot flashes and vaginal dryness.
Dr. Andrew Kaunitz of NEJM Journal Watch Women's Health takes a close look at the recommendations and how they might affect clinical practice at the first link below.
Comment
LINK(S):
NEJM Journal Watch Women's Health guideline watch (Free)
USPSTF recommendation statement in JAMA (Free)
USPSTF evidence review in JAMA (Free)
JAMA editorial (Free)
JAMA Internal Medicine editorial (Free)
JAMA Cardiology editorial (Free)